Safety, Feasibility, and Short-Term Follow-Up of Drug-Eluting Stent Placement in the Intracranial and Extracranial Circulation
Open Access
- 1 October 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (10) , 2562-2566
- https://doi.org/10.1161/01.str.0000242481.38262.7b
Abstract
Background and Purpose— A variety of primary end points have been used in acute stroke trials. We focus on the modified Rankin Scale, a reliable and valid ordinal outcome measure that assesses disability on a 7-point scale.Keywords
This publication has 21 references indexed in Scilit:
- Angioplasty for Symptomatic Intracranial StenosisStroke, 2006
- Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial StenosisCirculation, 2006
- Peristent Remodeling and Neointimal Suppression 2 Years After Polymer-Based, Paclitaxel-Eluting Stent ImplantationCirculation, 2005
- Drug-Eluting Stents for the Treatment of Intracranial AtherosclerosisStroke, 2005
- Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting StentsCirculation, 2005
- Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA)Stroke, 2004
- Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel responseJournal of Neurosurgery, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Extracranial vertebral artery stent placement: in-hospital and follow-up resultsJournal of Neurosurgery, 1999